This study presents the influence of COVID-19 and the pandemic on individuals diagnosed
with hepatocellular carcinoma and intrahepatic cholangiocarcinoma, the two most common …

Background & Aims The coronavirus disease 2019 (COVID-19) pandemic has posed
unprecedented challenges to healthcare systems and it may have heavily impacted patients …

BACKGROUND A growing number of clinical examples suggest that coronavirus disease
2019 (COVID-19) appears to have an impact on the treatment of patients with liver cancer …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the
coronavirus disease (COVID-19), which poses a major threat to humans worldwide. With the …

Background: The pandemic of coronavirus disease 2019 (COVID-19) has diverted
resources from healthcare services for patients with chronic medical illness such as cancer …

Aim: Changes in strategies in the coronavirus disease 2019 (COVID-19) crisis and the
imposing of restrictions have isolated many vulnerable patients including those with …

The incidence of liver injury after coronavirus disease 2019 (COVID-19) infection ranged
from 15%-53%. The mechanism includes direct viral cytopathic effect, cytokinesis, and …

Purpose The COVID-19 pandemic has been a burden to the global community as a whole
but the healthcare community had bore the brunt of it. The pandemic resulted in policy …

In the ongoing Coronavirus disease 2019 (COVID-19) pandemic, there is a pressing need to
identify clinical factors that are predictive of disease severity. The development of accurate …

Coronavirus disease 2019 (COVID-19) patients with liver dysfunction (LD) have a higher
chance of developing severe and critical disease. The routine hepatic biochemical …